semaglutide injections queen creek | Weight Loss 🌿 The Truth About Semaglutide

Medicare plans can now cover Wegovy for patients at risk of heart disease

At Set Point Medical Weight Loss Clinic, our professional team will provide guidance and support throughout this phase to help you stay on track with your weight loss and health goals

Oral Wegovy (Semaglutide Pill) The FDA approved the Wegovy pill in December 2025, giving patients an oral semaglutide option for weight management

Retatrutide in the broader GLP-1 landscape Retatrutide does not exist in a vacuum

Phase 2 data showed comparable efficacy, with participants receiving 12 mg losing approximately 24% of baseline body weight over 48 weeks

Behind semaglutide, there are already three layers of challenging forces, each of which has the potential to become the leader in the weight-loss market